Annals of Surgery · 2008 · 31 citations · 9 references
For patients with ID and IL cancers, the overall sensitivity of FS is >50%, but the yield of FS is <10% for individuals > or =60 years of age with T1a/b tumors. Intraoperative FS may not be worthwhile for this low-yield subset, especially for patients with invasive breast cancer of favorable type.
9
Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
R Moll, M. Mitze, U H Frixen et al. · PubMed · 1993 · 460 citations